Morganna Freeman, DO, FACP, discusses the challenges that are presented with identifying biomarkers predicting clinical benefit in the context of checkpoint inhibitors.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2022 Healio All Rights Reserved.
Learn. Research. Collaborate.
Begin your journey with Learn Immuno-Oncology.
Test your knowledge and determine where to start.